Teva probed in Turkey over possible conduct against rivals
( August 24, 2026, 10:11 GMT | Official Statement) -- MLex Summary: Pharmaceutical company Teva is under investigation in Turkey to determine whether it engaged in practices including applying “divisional patent procedures” to restrict competition from generic medicines, the national competition authority has said. Teva might also have created a “misleading impression” for healthcare authorities regarding the efficacy and safety of rival products, making it more difficult for competitors to enter the market, the regulator said.Statement follows. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.